Ironwood Pharmaceuticals
IRWD
#7069
Rank
HK$5.00 B
Marketcap
HK$30.42
Share price
-0.77%
Change (1 day)
409.97%
Change (1 year)

Earnings for Ironwood Pharmaceuticals (IRWD)

Earnings in 2026 (TTM): HK$1.34 Billion

According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are HK$0.36 Billion. In 2025 the company made an earning of HK$0.54 Billion, an increase over its 2024 earnings that were of HK$0.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ironwood Pharmaceuticals from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$1.34 B144.16%
2025 HK$0.54 B7.4%
2024 HK$0.51 B-106.88%
2023 -HK$7.44 Billion-475.59%
2022 HK$1.97 B25.8%
2021 HK$1.57 B84.32%
2020 HK$0.85 B84.69%
2019 HK$0.46 B-125.13%
2018 -HK$1.84 Billion100.62%
2017 -HK$0.92 Billion43.12%
2016 -HK$0.65 Billion-42.73%
2015 -HK$1.12 Billion-24.76%
2014 -HK$1.49 Billion-30.49%
2013 -HK$2.14 Billion275.65%
2012 -HK$0.57 Billion11.56%
2011 -HK$0.52 Billion9.38%
2010 -HK$0.47 Billion-15.21%
2009 -HK$0.56 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
HK$114.98 B 8,451.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Nektar Therapeutics
NKTR
-HK$1.2 Billion-188.77%๐Ÿ‡บ๐Ÿ‡ธ USA